All ingredient lists · Model report

Ingredient list

Semax.

Declared composition for LIRAVEXIN catalog number XA5. This page lists what the catalog names. It is not a laboratory assay and not a test result.

Ingredient list — declared composition, not a test result
GS Laboratory

Prepared as a catalog companion to the model testing report.

Ingredient list

Declared composition for a LIRAVEXIN catalog item — not a tested result

Catalog number
XA5
Product name
Semax
Labelled amount
5 mg
Pack, as catalogued
5 mg × 10 vials
Physical form
Lyophilised powder in a vial
Catalog
LIRAVEXIN (www.liravexin.com)

Declared ingredients

Ingredient Amount as declared Public identity
Semax5 mgA heptapeptide ACTH(4–10) analogue.
Public sequence / structure: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP)
Other constituents—Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here.

Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.

Notes

This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.

The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.

Declared composition — not a test result · XA5